29
1 EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011: SUPPLEMENTARY GUIDANCE June 2013 Version _ Health Division www.oecd.org/health Directorate for Employment, Labour and Social Affairs Contacts: David Morgan (OECD) / John Henderson (UK Department of Health)

EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

1

EXPENDITURE ON

PREVENTION ACTIVITIES

UNDER SHA 2011:

SUPPLEMENTARY GUIDANCE

June 2013 Version

_

Health Division

www.oecd.org/health

Directorate for Employment, Labour and Social

Affairs

Contacts: David Morgan (OECD) / John Henderson (UK Department of Health)

Page 2: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

2

ACKNOWLEDGEMENTS

1. The report was prepared by John Henderson of the UK Department of Health. Useful

comments and advice were received from colleagues in the OECD Health Accounts team,

Patricia Hernandez-Pena and Cor van Mosseveld from WHO NHA team, and the participants

of the 14th Meeting of National Health Account Experts. Health accounts experts in

Australia, Denmark, Finland, France, Korea, Netherlands, Norway and Switzerland, as well

as from Eurostat, provided helpful comments and suggestions.

2. This project was funded under EU contribution agreement 2011 53 01.

Page 3: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

3

TABLE OF CONTENTS

ACKNOWLEDGEMENTS .............................................................................................................. 2

EXECUTIVE SUMMARY .............................................................................................................. 4

1. INTRODUCTION ........................................................................................................................ 5

2. GENERAL CONSIDERATIONS AND THE ACCOUNTING BOUNDARIES OF

‘PREVENTION’ ............................................................................................................................... 8

Main boundary criteria used in SHA 2011 .................................................................................... 8

A. Prevention versus non-health spending ................................................................................. 12

B. Prevention versus health-related spending ............................................................................. 15

C. Prevention versus other health spending ................................................................................ 18

Summary of the prevention boundary under SHA 2011 ............................................................. 20

3. MAPPING TO NEW 2ND

DIGIT PREVENTION CLASSES ................................................... 23

Mapping from SHA 1.0 to SHA 2011 – examples from England ................................................ 23

Some additional guidance on using SHA 2011 2nd

digit prevention classes ............................... 23

HC.6.1 .......................................................................................................................................... 24

HC.6.2 .......................................................................................................................................... 24

HC.6.3 .......................................................................................................................................... 25

HC.6.4 .......................................................................................................................................... 25

HC.6.5 .......................................................................................................................................... 26

HC.7.1 .......................................................................................................................................... 26

4. CONCLUSIONS......................................................................................................................... 28

REFERENCES ............................................................................................................................... 29

Page 4: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

4

EXECUTIVE SUMMARY

3. Experience from the substantial health gains of the 20th century suggests that spending on

prevention could be an important factor. Therefore, gathering data on such spending that are

consistent and comparable, both over time and across countries, is potentially very useful.

This paper aims to help clarify what should be included as spending on prevention under SHA

2011 to facilitate accurate comparisons.

4. Prevention can change progression through the natural history of disease for the better,

and takes in any measure that aims to avoid or reduce the severity of injuries or diseases. It

includes both collective measures and individual services.

5. A key criterion for inclusion under SHA 2011 is whether the primary purpose of the

spending is health. Therefore, some policies which address the wider determinants of health

and have known impacts upon health – e.g. improving or increasing incomes, employment,

housing, or active travel – are considered outside the SHA boundary as they have some other

primary purpose. However, much of public spending to improve occupational health and

safety and environmental health, to prevent mortality and injuries in road and transport

accidents, and to increase food safety, do fall within the boundary of prevention.

6. The document strives to better define the prevention boundaries in three ways: in relation

to other health spending, health-related spending, and non-health spending. Thus, the

legislative and regulatory process to increase health and safety, or curtail the advertising and

promotion of hazardous behaviour, are considered part of health governance rather than

spending on prevention per se; while the enforcement of such regulations is classed as health-

related spending. The costs of compliance with regulations by individuals and companies

may have the purpose of avoiding the penalties for contravention, so any expenditure in this

domain is also outside the boundary of prevention and health. Likewise, voluntary measures

by individuals and companies may have a primary purpose other than health, and so are

outside the boundary too. When their purpose is prevention, public health programmes and

personal preventive healthcare services are within the prevention boundary, including when

requested by patients – these include many forms of information, education, counselling and

mass communication, plus immunisation, screening and check-ups. Pharmaceutical spending,

including prophylactic medication and contraceptives, is classed with medical goods rather

than preventive spending under SHA 2011.

7. At the 2nd

digit level within the SHA functional classification, spending should be

allocated according to its primary intent, including to its dominant purpose where there is

more than one purpose. Guidance is also offered, for example, on distinguishing screening

programmes from check-ups, and programme planning from governance. Tables and

examples are incorporated to illustrate what should and should not be included as prevention

spending.

Page 5: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

5

1. INTRODUCTION

8. Prevention is of great importance in the story of health gains over the 20th century and has

the potential to play a major role in the 21st. On the face of it, spending on prevention seems

to vary greatly across countries (OECD, 2011) – both in terms of absolute amounts and shares

of total health spending. Some countries like to benchmark their spending on prevention by

making comparisons with what other countries spend. Harmonising methods of calculating

such expenditure should help to ensure that reported differences are real, rather than

attributable to varying methods or inclusions.

9. The prevention category in SHA 2011 is one of the most changed areas compared with

SHA 1.0. SHA 2011 takes a different approach to the organisation of prevention; it

emphasises purpose – i.e. primary and secondary prevention – as well as type of service, to

define prevention sub-classes – and includes both individual and collective prevention

spending.

10. SHA 2011 explains the refinement of the functional classification of prevention as

follows:

“Prevention. The functional category in the new manual has been better aligned to the purpose of consumption, i.e. one of the objectives of contacting the health system is to receive preventive care. The boundary criteria (as described in Chapter 4 [of SHA 2011]) have been applied to better differentiate health prevention from the health care-related categories (HCR) of SHA1.0. Refined definitions should ensure comprehensive, exhaustive and mutually exclusive categories and increase the comparability of HC classes across countries. The “prevention and public health” class of SHA 1.0 has been unclear in its content, because the categories were based on a mix of criteria: “public” referred at the same time to government-financed services, place of delivery (public-owned services) and the beneficiaries involved (population priority groups). Thus, “prevention and public health” has been restructured into a preventive class, which is better distinguished by purpose from the curative components.” (SHA 2011, p74).

11. SHA 2011 sets out a rationale behind the categories of the functional classification using

the progression of illness and disease from a healthy state. “The natural history of disease

qualifies the various components of the health system contact and allows a breakdown by

specific type of service.” (SHA 2011, p76)

“The starting point of this process is a healthy condition. At this stage, interventions aim to enhance health status and to maintain a condition of low risk of diseases, disorders or injuries – in other words, to prevent their occurrence (HC.6), through vaccinations or an injury prevention programme, for example. Preventive interventions also cover individuals at specific risk and those who have either no symptoms of the disease or early signs and symptoms, where early case detection will assist in reducing the potential damage by enabling a more successful intervention. Take the examples of breast and prostate cancer, where age and sex affect the risk; certain lifestyle choices increase the risks, as smoking does for lung cancer.” (SHA 2011, p76)

12. This is depicted in Figure 1.1.1 This illustrates two different types of preventive services:

some are consumed collectively – “epidemiologic surveillance and risk and disease control

1 Figure 5.1 of SHA 2011.

Page 6: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

6

programme management” – while others are personal prevention services consumed by

individuals – “information and counselling, immunization, early case detection, healthy

condition monitoring”. Expenditure on both collective and individual services is included

under SHA 2011.

Figure 1.1. The natural history of disease and the purpose of health care goods and services

13. It may also be helpful to expand the issue of risk status and interventions to reduce risks –

which can usefully be illustrated using the example of non-communicable diseases (NCDs),

such as cardiovascular disease (CVD)2. WHO has categorised NCD risk factors as

“behavioural” and “physiological”.

Risk factors3

Modifiable behavioural risk factors Tobacco use, physical inactivity, unhealthy diet and the harmful use of alcohol increase the risk of or cause most NCDs.

Tobacco accounts for almost 6 million deaths every year (5.1 million from direct tobacco smoking and 600 000 from exposure to second-hand smoke), and is projected to increase to 8 million – or 10% of all deaths every year – by 2030.

About 3.2 million deaths annually can be attributed to insufficient physical activity.

Approximately 1.7 million deaths are attributable to low fruit and vegetable consumption.

Half of the 2.3 million annual deaths from harmful drinking are from NCDs.

2 Non-communicable diseases - or NCDs - like heart attacks and strokes, cancers, diabetes and chronic respiratory

disease account for over 63% of deaths in the world today. That is why global leaders met at the

United Nations in New York from 19-20 September 2011 to set a new international agenda on NCDs.

http://www.who.int/nmh/events/un_ncd_summit2011/en/

3 WHO fact sheet on Non-Communicable Diseases, September 2011:

http://www.who.int/mediacentre/factsheets/fs355/en/index.html

Natural History of Disease Personal consumption Collective consumption

Low risk

At risk

Disease

Dsability (body

structure and

function)

Chronic

Condition and

Functional

decline

Dependency for

self care

Death

Collective consumption

Collective prevention:

Epidemiologic

surveillance & risk and

disease control

programme

management

Personal prevention:

Information & counseling,

Immunization, Early case

detection, Health condition

monitoring

Governance and

Health system

administration

Early signs &

symptoms

Cure - Treatment -

Rehabilitation

Maintenance - LTC - Palliative

care

Page 7: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

7

Metabolic/physiological risk factors These behaviours lead to four key metabolic/physiological changes that increase the risk of NCDs: raised blood pressure, overweight/obesity, hyperglycemia (high blood glucose levels) and hyperlipidemia (high levels of fat in the blood). In terms of attributable deaths, the leading NCD risk factor globally is elevated blood pressure (to which 13% of global deaths are attributed), followed by tobacco use (9%), raised blood glucose (6%), physical inactivity (6%), and overweight and obesity (5%).

14. Efforts by the healthcare system to change modifiable behavioural risk factors are

included as part of prevention, when these take the form of risk status assessment or early

case detection by a health professional, and information, education and counselling with the

intent of changing behaviour and reducing risk. However, efforts to tackle the “causes of the

causes” (why people behave in ways that put their health at risk) by changing the “social

determinants of health”4, might be difficult to distinguish from other programmes with a non-

health primary purpose. Likewise, some interventions by the healthcare system to change

modifiable physiological risk factors might be difficult to distinguish from tertiary prevention

and treatment. These issues are addressed further in Section 2 below.

15. The rest of this paper aims to address some of the possible ambiguities that may remain,

notwithstanding the further guidance in SHA 2011, to illustrate some example areas, to

compare the implications of moving from SHA 1.0 to SHA 2011, and to offer some further

clarifications about the functional classification of prevention expenditure.

4 Prof Sir Michael Marmot, on behalf of the Commission on Social Determinants of Health: ‘Achieving health

equity: from root causes to fair outcomes’: “Health equity is central to this premise and to the work of the

Commission on Social Determinants of Health. Strengthening health equity—globally and within countries—

means going beyond contemporary concentration on the immediate causes of disease. More than any other global

health endeavour, the Commission focuses on the “causes of the causes”—the fundamental structures of social

hierarchy and the socially determined conditions these create in which people grow, live, work, and age.” The

Lancet, Volume 370, Issue 9593, pp 1153-63, 29 September 2007.

Page 8: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

8

2. GENERAL CONSIDERATIONS AND THE ACCOUNTING BOUNDARIES

OF ‘PREVENTION’

16. This section addresses the setting of boundaries of prevention in the SHA 2011

classification of health care functions, and other general considerations. The boundary issues

can be divided into the three following groupings:

A. The global boundary of healthcare as it affects prevention – i.e. prevention versus

non-health spending;

B. The HCR boundary – i.e. prevention within health spending versus healthcare-

related spending;

C. The prevention boundary – i.e. spending on prevention versus other areas of health

spending.

Figure 2.1. Boundaries of the health system

Based on: WHO ‘Health Systems Performance Assessment’ (HSPA)5

Main boundary criteria used in SHA 2011

17. In setting the boundaries of health spending (and that of prevention), there has been some

shift in emphasis in the ranking of the criteria used to define health care between SHA 1.0 and

SHA 2011. SHA 2011 overtly gives primacy to the criterion of purpose or intent: “The

main criterion to include or exclude certain activities relates to their role in enhancing health

5 WHO ‘Health Systems Performance Assessment’ (2003) http://www.who.int/publications/2003/hspa/en/

Health

Personal medical

Non-personal

health services

Intersectoral

action

Other factors

C O

V E

R A

G E

Page 9: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

9

status, diminishing ill-health, or preventing the deterioration of the health of individuals

and/or the population as a whole.” (SHA 2011, p56)6.

18. Other criteria can also be relevant in practice. These may include the following:

Sometimes there is ambiguity over primary purpose – it may be unclear if the

main intent of the activity is either to promote health or prevent disease. If there is a

strong chance that the primary purpose is non-health, this could be a reason for

exclusion.

The distinction between the health care system and the broader health system.

Figure 2.1 above illustrates this, and the source states (p7) “The third definition

includes all actors, institutions and resources that undertake health actions—where

the primary intent of a health action is to improve health. It is broader than personal

medical and non-personal health services. It incorporates selected intersectoral

actions in which the stewards of the health system take responsibility to advocate

for health improvements in areas outside their direct control, such as legislation to

reduce fatalities from traffic accidents. This is shown by the largest circle” in Figure

2.1. Many activities with a preventive effect are part of “intersectoral action” – and

part of the health system, but not the health care system.

Practicality of extracting relevant data and or disaggregating data by functions. For

example, an institution (such as the UK’s Health and Safety Executive) might

undertake a mixture of activities some of which are inside the SHA boundary and

others of which are outside. Ideally the appropriate expenditure shares on the

different activities should be allocated accordingly. However, sometimes this may

be impracticable, and the options may be to include all of the institution’s

expenditure, or none, if further disaggregations are problematic. How much effort

to put into overcoming such problems will partly depend on the usefulness of the

results – for example, the larger the sums involved, the more useful the effort to

disaggregate the spending is likely to be7.

Prevention at the individual’s own initiative may be excluded, as: (i) there may be

ambiguity over primary intent (e.g. the primary intent might be comfort or social

acceptability); and (ii) in practice, data on such spending may be embedded in other

expenditure data and difficult to extract. However, with health systems putting

increasing emphasis on personal responsibility and choice, it is possible that a

growing share of prevention activities may fall into the category of “the individual’s

own initiative”. If so, it would be important not to lose sight of such spending8.

19. A key boundary issue is the role of the health system in the process of deciding preventive

measures. Prevention includes identifying measures to avoid risks and their health

consequences, and determining measures appropriate to a specific health system, in a specific

country, for a specific risk or disease. The general surveillance of specific and strategic

collective risks is a responsibility of the health system and is also included as prevention.

6 The SHA explains that the other criteria (over which purpose takes precedence) are: qualified medical or health

care knowledge and skills are needed in carrying out the function, or to supervise the function (or the

function is governance, administration or financing); consumption is for the final use of health care

goods and services of residents; and there is a transaction of health care services or goods.

7 If many countries were spending large amounts on, say, ensuring food safety, it may be useful to disaggregate the

expenditure and record the preventive part of such spending (which might then facilitate analysis of its

costs and efficiency).

8 It would therefore be sensible to try to maintain records of such spending where possible, and It would also be

helpful to review this convention periodically to ensure that its application remains helpful.

Page 10: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

10

20. Preparatory work for preventive regulations relies on the health system but it may involve

different types of activities, such as research9 and surveillance as well as evidence gathering.

Regulatory work to address health risks may involve other sectors, e.g. for road safety risks,

the role of the health system may be to help design or to certify or to sanction the validity of

the health preventive components, but regulation of road safety matters remains under the

road authorities.

21. The regulatory agency in the relevant sector will take care of its enforcement – e.g. in the

road safety example, the road authorities. In this case enforcement is classed as healthcare-

related, and therefore outside the SHA healthcare boundary. For health laws involving the

health system itself, responsibility for compliance and enforcement remains with the health

system. Therefore enforcement of healthcare regulations, applying to healthcare providers, is

inside the SHA healthcare boundary (and enforcement of prevention regulations applying to

prevention providers is within the prevention boundary). (SHA 2011, p107) Sanctions are

usually linked to legal procedures.

22. The charts below try to illustrate some areas that are inside the SHA 2011 prevention

boundary, and others that are not. Figure 2.2 aims to explain the rationale for the SHA

classification of relevant activities.

9 Research needed may involve both health matters as well as non-health matters, such as the materials for the

seatbelt and their ergonomics, which are out of the scope of health. But epidemiological research is

also needed to support the role of the health system to propose measures, to define a road safety

preventive program and to sanction the health component of the regulatory proposal by the road

authority.

Page 11: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

11

Figure 2.2. Types of activities and rationale for their SHA classification

Collective measures10

Individual actions11

23. In the following sections, various areas that might be included in prevention spending,

non-prevention health spending, healthcare-related spending or excluded from the health

spending boundary, are illustrated.

10 Collective measures typically can be consumed by groups of people simultaneously, and use of the measure by

one person does not reduce its availability for others.

11 Individual actions typically involve personal consumption and use by one person does reduce availability for

others. Enforcement may have elements that are “collective” – e.g. monitoring data and compliance

report publishing – and elements that are “individual” – e.g. inspections and prosecutions.

Healthcare services – where the primary purpose is prevention. Broader services and programmes – any measure whose primary aim is to avoid disease or injury, or detect risks to health so that the risks can be lowered consequently reducing the number or the severity of diseases and injuries.

Individual services – where the primary purpose is prevention. Includes: informing individuals; assessing their risks; and efforts to reduce their risks.

HC.6

Pharmaceuticals and medical goods There is a specific functional classification for pharmaceuticals that should be used (unless spending on the pharmaceuticals or medical goods is inseparable from the rest of the preventive programme spending).

Governance of healthcare and the health system. Includes: regulation to protect public health; other methods of exerting strategic influence; strategic management of health systems to improve health.

HC.7.1

Broader policies Policies may incidentally improve health, but where there is likely to be another main motivation then these are to be classified according to the primary intent.

Voluntary measures Companies pursue corporate social responsibility, for example, but the primary intent may be sales or profits, rather than health. Individuals undertake actions that incidentally improve their health, but where the primary intent may be another motivation.

excluded

Compliance costs Individuals and companies incur costs in complying with regulations, but the primary intent may be to avoid penalties (financial, reputational, etc) for contravention.

excluded

Enforcement Regulations give rise to costs of monitoring compliance, surveillance, and upholding the law. These are classed as healthcare-related.

HCR.2

Multi-sectoral health promotion In joint efforts with other sectoral programmes, prevention and health promotion may be secondary, and outside the healthcare boundary.

HCR.2.1 &

HCR.2.2

HC.5

HC.6

Enforcement within healthcare When regulations apply within healthcare, then inspecting prevention providers and tackling contraventions, etc, by such providers is classed as part of prevention.

Page 12: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

12

A. Prevention versus non-health spending

24. SHA 2011 contains a section explaining the considerations of boundary setting with

regards to prevention (SHA 2011, pp100-102). Here those considerations and the above

criteria are used to provide further clarification in some specific areas.

25. There are changes between SHA 1.0 and SHA 2011 in what falls within the boundary of

prevention spending. For example, SHA 1.0 states in Para. 3.4 “In the context of the SHA,

general public safety measures like technical standards monitoring, road safety, etc., are not

considered as application of medical technology and are, for that reason, excluded from the

core health care functions.” On the other hand, SHA 2011 states that “Prevention is any

measure that aims to avoid or reduce the number or the severity of injuries and diseases, their

sequelae and complications” (p100).

26. A specific example of a change is the treatment of health and safety at work, much more

of which is included under a broader boundary in SHA 2011.

SHA 1.0 p123: “Occupational health activities to improve ergonomy, safety and health and environmental protection at the workplace, accident prevention, etc., should be distinguished from occupational health care. They are not to be recorded under health care activities in the SHA.”

SHA 2011 p105, Table 5.2: Included under SHA2011 in HC.6 • Ergonomy, safety (health part) • Health and environmental protection at work (health part) • Accident prevention at work (health part) [excluded under SHA1]

27. However, several OECD countries may already include spending on occupational health

protection and safety (in addition to occupational health) in their public health and prevention

expenditure (i.e. as reported under SHA 1.0).

28. To determine inclusion or otherwise, SHA 2011 uses as the main criterion the primary

purpose or intent. Therefore, prevention of mortality and morbidity due, for example, to

occupational, transport and other hazards would be included – where it is clear that the

primary intent of the action is prevention of harm to human health. However, this does not

mean that all spending on programmes, or all parts of programmes in occupational health and

safety, and transport safety, for example, are to be included in category HC6. The components

not included are those associated with other primary intents, e.g. transport or economy.

29. Figure 2.3 below shows how the considerations illustrated in Figure 2.2 apply in the

specific areas of domestic, fire, occupational and transport risks, using the same “colour

coding”.

Page 13: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

13

Figure 2.3. Approaches to tackling risks, and their SHA classification

Collective measures Individual actions

30. Using the above guidance, the Table below indicates where to classify aspects of

prevention spending on activities that tackle the above risks.

SHA 2011 code

Prevention / activities

Domestic & Fires Occupational Transport

HC.1 Treatment of injuries caused by domestic accidents or fires

Treatment of diseases with occupational causes to reduce sequelae and damage in affected populations

Treatment of injuries caused by transport accidents

HC.6.5 Data collection on risks to health & epidemiological assessment – e.g. trends in mortality due to falls, fires, or other causes

Data collection on risks to health & epidemiological assessment

Data collection on risks to health & epidemiological assessment – e.g. trends in accidents by different modes of transport (cars, cycles, pedestrians, etc), times and seasons, etc

HC.6.5 Prevention programme planning and design (e.g.

Prevention programme planning and design (eg

Prevention programme planning and design (e.g.

Collective preventive services – e.g. Epidemiology

- assessment of risks from hazards, and reductions expected from interventions

Information & communications - warnings about dangers, and

best practice guidance

Governance for health – e.g. Formulating regulations

- mandatory procedures to be followed; prohibitions; licensing

Other methods of exerting strategic influence

- designing incentive schemes for healthy/safe practice

Health-related actions – e.g. Enforcement of health regulations

- inspections - monitoring compliance - tackling contraventions

Individual preventive services – e.g. Advising individuals

- explaining risks from hazards, and how to reduce them

Health monitoring - assessing risk exposure, and

checking health Subsidies for protective equipment

- if primary purpose is health

Actions where primary motivation is likely to be other than health – e.g. Compliance with regulations, etc

- costs of following mandatory procedures

- licence fees - fines, taxes paid

Voluntary measures by individuals and companies could have a primary motivation other than health – e.g. Radon remediation

- increases property sale value?

Non-mandatory training - increases productivity?

Corporate social responsibility

Examples of Risks

Domestic

Occupational

Transport

Fires

Policies where primary motivation is likely to be other than health – e.g. Active travel policies [CO2 reduction]

- safer walking/cycling routes Employment policies

- reducing unemployment

Page 14: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

14

deciding which interventions are most cost-effective)

deciding which interventions are most cost-effective)

deciding which interventions are most cost-effective – and for which groups – children, young people, older people, etc)

HC.6.1 Providing health & safety information to the public – e.g. about causes of fires and accidents, and how to reduce risks to health

Providing health & safety information to firms and workers about sources of hazards, and how to reduce risks – e.g. the importance of wearing hard hats, and safe handling of dangerous materials such as asbestos

Providing health & safety information to the public about sources of hazards, and how to reduce risks – e.g. the importance of wearing seatbelts and helmets, and teaching children how to cycle safely

HC.6.1 Provision of public services – e.g. advisers providing information and advice about reduction of high levels of radon in homes.

Provision of preventive services – e.g. occupational health and safety guidance, and health advisers such as occupational health doctors, nurses, physiotherapists, hygienists or ergonomists

Provision of public services – e.g. crossing supervisors outside schools to reduce accident risks for young children (if primary purpose is injury prevention)

12

HC.7.1 Making regulations to protect public health – e.g. building and other regulations to reduce carbon monoxide poisoning

Making regulations to protect employees’ and public health and safety – e.g. to make the wearing of hard hats mandatory, or bringing in a licensing regime for work involving asbestos

Making regulations to protect public health and safety – e.g. to make the wearing of seatbelts or helmets mandatory

HC.R.2 Enforcing such regulations – e.g. inspection, monitoring, tackling contraventions.

Enforcing such regulations – e.g. inspection, monitoring, tackling contraventions

Enforcing such regulations – e.g. inspection, monitoring, tackling contraventions

Excluded Cost of compliance with regulations – e.g. mandatory changes to buildings or fittings to reduce carbon monoxide poisoning

Costs to firms and public bodies of complying with regulations – e.g. undertaking mandatory training in how to handle asbestos

Cost of compliance with regulations – e.g. motor industry fitting seatbelts to vehicles

Excluded Broader policies – e.g. mandatory building insulation standards (primary purpose may be other than health)

Broader policies – e.g. mandatory leave entitlements (primary purpose may be social rather than health)

Broader policies – e.g. to promote walking or use of bicycles (primary purpose may be other than health)

Excluded Costs of voluntary measures to reduce risks – e.g. measures by householders to reduce accumulation of radon in homes

Costs of voluntary measures to reduce risks – e.g. private purchase of training

Costs of voluntary measures to reduce risks – e.g. purchase and use of (non-mandatory) helmets by cyclists

12

Epidemiological studies have demonstrated that strategic points, such as outside schools, are linked to higher

rates of road traffic accidents, mortality and injuries to children, and where prevention of these is the

primary intention this is classed as a health education intervention.

Page 15: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

15

B. Prevention versus health-related spending

31. SHA 2011 offers clarification concerning the boundary between prevention under health

spending and that under healthcare-related expenditure (SHA 2011, p101 and pp115-116).

32. SHA 2011 explains that “the type of services included in the health prevention boundary

is restricted to those components with a primary health purpose. Interventions that go beyond

the health care boundary but are policy relevant can be reported as health care-related items.”

(p101) So, SHA 2011 has the class “HCR.2 Health promotion with a multi-sectoral

approach”. “The aim of this class is to account for health promotion resources that may go

beyond the health care boundary, though nevertheless clearly involved with a health interest.”

(p114) (See also Figure 2.1, and paragraph 18.)

33. Figure 2.4 below shows how the considerations illustrated in Figure 2.2 apply in the

specific areas of environmental, food safety and behavioural risks, using the same “colour

coding”.

Figure 2.4. Approaches to tackling risks, and their SHA classification

Collective measures Individual actions

Collective preventive services – e.g. Epidemiology

- assessment of risks from hazards, and reductions expected from interventions

Information & communications - warnings about pollution levels,

other dangers, and mass media health campaigns

Governance for health – e.g. Formulating regulations

- Emissions limits; labelling; mandatory procedures to be followed; prohibitions; advertising restrictions

Methods of exerting strategic influence - designing incentive schemes or

co-regulation (alcohol reduction)

Individual preventive services – e.g. Advising individuals

- explaining risks from hazards, and how to reduce them

Health monitoring - health check-ups

Financial incentives for healthy behaviour - e.g. to quit smoking

Voluntary measures by individuals and companies may have a primary motivation other than health – e.g. Increase in consumption of fruit,

vegetables, lower fat foods Purchase of bicycles, gym

memberships Corporate social responsibility

Actions where primary motivation is likely to be other than health – e.g. Compliance with regulations, etc

- costs of following mandatory procedures, etc

- licence fees - fines, taxes paid

Policies where primary motivation is likely to be other than health – e.g. Fiscal and licensing policies

- e.g. raising revenue Active travel policies [CO2 reduction]

- safer walking and cycling routes

Examples of Risks

Pollution

Food safety

Unhealthy diet

Inactivity

Smoking

Harmful drinking

Other risky behaviours

Multi-sectoral health promotion Health protection may be an important

secondary goal rather than the primary purpose – e.g. - food & water security measures - safe management of waste - tackling drunkenness

Health-related actions – e.g. Enforcement of health regulations

- inspections - monitoring compliance - tackling contraventions

Page 16: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

16

34. Using the above guidance and illustrations relating to environmental and food safety risks,

and risky behaviour that contributes to NCDs, the Table below indicates where to classify

aspects of prevention spending on activities that tackle the above risks.

SHA 2011 code

Prevention / activities

Environmental Food safety Behavioural risks

HC.6.1 Media campaigns or web-pages: Providing information to the public – e.g. about elevated pollution levels, and how to reduce risks to health (e.g. avoiding ozone or particulates hotspots)

Media campaigns or web-pages: Safe handling of foods (to avoid food poisoning).

Mass media campaigns: Providing health information to the public or specific groups, about how to reduce risks – e.g. the importance of good diet and regular exercise.

HC.6.1 Professional advisory services Providing information and advice to firms about sources of hazards, and how to reduce risks – e.g. (if primary purpose is health) how to control contaminants or emissions that are dangerous to human health

Professional advisory services Providing information and advice to firms and workers about sources of hazards, and how to reduce risks – e.g. the importance of personal hygiene, and safe handling of potential sources of pathogens

Physician counselling; and interventions in schools and workplaces

Services such as provision of advice – e.g. from physicians and other healthcare professionals, such as school nurses, community nurses, dieticians and pharmacists

HC.6.5 Financial incentives to reduce risks Subsidies – if it is clear that the primary purpose is to prevent morbidity or deaths – e.g. for adoption of lower-harm technologies

Financial incentives to reduce risks Subsidies – if it is clear that the primary purpose is to prevent morbidity or deaths – e.g. for fortification of certain foods

Financial incentives to reduce risks e.g. rewards for weight loss amongst overweight people, or provision of vouchers for fresh fruit and vegetables to promote healthier diet

HC.6.5 Data collection on risks to health & epidemiological assessment – e.g. if for a health purpose, monitoring whether pollutants such as particulates, ozone, and toxic or carcinogenic pollutants have reached hazardous levels; monitoring water for water-borne disease risks

Data collection on risks to health & epidemiological assessment – e.g. E coli, etc

Data collection on risks to health & epidemiological assessment – e.g prevalence of smoking, heavy drinking, BMI, etc

HC.6.5 Prevention programme planning and design (e.g. deciding which interventions are most cost-effective)

Prevention programme planning and design (e.g. deciding which interventions are most cost-effective)

Prevention programme planning and design (e.g. deciding which interventions are most cost-effective)

HC.7.1 Regulations Making regulations to protect public health – e.g. to reduce anthropogenic emissions of pollutants that harm health

Regulations Making regulations to protect public health – e.g. to make mandatory training in hygiene and display training success certificates; prohibition of substances that are, or may be, toxic, carcinogenic, etc

Advertising regulations: Making regulations to protect public health – e.g. to prevent the advertising of “junk food” to children

HC.7.1 Disclosure regulations: Making regulations to require firms to disclose their emissions – e.g. (if primary purpose is health) disclosure of toxic or carcinogenic substances emitted

Labelling regulations: Making clear when products contain nuts or other potential hazards; requirements to specify additives such as potential carcinogens (e.g. food colourants and preservatives)

Labelling regulations: Making regulations to promote public health – eg mandatory inclusion of labels showing calories, saturated fat and salt contents of foods, so that consumers can consume healthier diets

Page 17: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

17

HCR.2.1 (or HCR.2.3)

Enforcing regulations – e.g. inspection, monitoring, tackling contraventions

Enforcing regulations – e.g. inspection, monitoring, tackling contraventions

Enforcing regulations – e.g. inspection, monitoring, tackling contraventions

HCR.2.1 or HCR.2.2

Joint efforts in environmental programmes – e.g. waste management; pollution abatement; and noise control – where the health intent is secondary to an environmental purpose

Joint efforts in food and water programmes – e.g. food and water security, control and distribution

Assessing new technologies for safety and risk reduction; enhancing risk communication and advocacy

Exclude Cost of compliance with regulations – e.g. fitting emissions control technologies

Costs to firms of complying with such regulations – e.g. undertaking mandated training in hygiene

Costs to firms of complying with such regulations – e.g. costs of new labelling

Exclude Self-regulation by industry Costs of voluntary measures to reduce emissions – e.g. corporate social responsibility

Self-regulation by industry Costs of voluntary measures to reduce risks – e.g. removal of colourants

Self-regulation by industry Costs of voluntary measures to reduce risks – e.g. corporate social responsibility

Exclude The collection, treatment and remediation of environmental risks.

Fiscal measures: Taxes on substances that are hazardous to health – e.g. on tobacco, alcohol, saturated fat

35. Although compliance costs are excluded, these are costs that are incurred due to

regulations with a preventive intent, and as they can be very substantial expenditure, it may

well be policy relevant to monitor their scale (as recommended in best practice on assessing

regulatory impacts). If so, a country-specific memorandum item could be reported13

.

36. The categorisation of incentive schemes designed to change risky behaviour may not be

obvious in SHA 2011. When part of an approach to empower and encourage people to

change their behaviour, through improving their knowledge, beliefs and attitudes, perhaps

using techniques such as motivational interviewing14

, these could be seen as part of

“counselling” within IEC (information, education and communication) and thus in HC.6.1.

Some schemes go beyond counselling and include rewards to participants for successful

behaviour change – e.g. a financial reward that varies according to weight lost15

. In the latter

case they could be seen as part of a risk control programme, and thus in HC.6.5.

13 If a number of countries find this useful, and do hereafter report such expenditure, then it may be helpful in

future to make recommendations on methods, for consistency.

14 Motivational interviewing attempts to increase the client's awareness of the potential problems caused,

consequences experienced, and risks faced as a result of the behaviour in question, and to improve

their motivation to change http://en.wikipedia.org/wiki/Motivational_interviewing

15 ‘The ‘Pounds for Pounds’ weight loss financial incentive scheme’, Relton et al (2011):

http://jpubhealth.oxfordjournals.org/content/early/2011/03/28/pubmed.fdr030.full

Page 18: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

18

C. Prevention versus other health spending

37. SHA 2011 introduced some changes and clarifications that affect the allocation of

expenditure between prevention and other healthcare expenditure.

School health services

38. School health services need to be distinguished by purpose. If the purpose is prevention –

e.g. health education – then this would be included in HC.6.1, in this example. Any basic

medical treatment provided in a school setting, for example by an on-site medical centre,

would be treated as curative care (e.g. outpatient curative care, HC.1.3).

Collective services

39. Some collective services, such as running blood banks, were included in public health and

prevention under SHA 1.0, but are not classed as prevention under SHA 2011 (SHA 2011,

p105; they are now classed as ancillary services in HC.4.1).

Social programmes versus patient-initiated requests

40. Under SHA 1.0 only prevention “provided as a social programme” was included (at least

for non-communicable diseases; SHA 1.0 p122) – so if the health care system initiated the

preventive activity the expenditure was included, but usually not if the patient initiated the

preventive activity. Hence breast cancer screening would be within HC.6 if the invitation

came from the health care system, but might be classed as treatment (HC.1) if the patient

requested a screen – e.g. if she was, say, above the screening programme age threshold. The

latter exclusion from prevention was largely due to the practical issue of being able to gather

data on spending outside of organised prevention programmes.

41. With increasing autonomy being given to patients in organising their care, it may be more

common for preventive activity to be initiated by patients. Therefore, SHA 2011 does not

explicitly exclude such patient-initiated preventive activity (SHA 2011 p100). In particular,

where the health system invites patients to request preventive care as part of an organised

programme, this should not be excluded from prevention.

Pharmaceuticals and medical goods for prevention

42. Some pharmaceuticals and medical goods may have a preventive function (e.g. to prevent

first occurrence of coronary heart disease or cerebrovascular disease, by reducing blood

pressure or lipids). However, unless they are an integral part of a prevention programme (e.g.

in the case of anti-malaria bed nets, they should be accounted for within the malaria

programme when they are distributed during malaria interventions), any medical goods

dispensed against a prescription or purchased over the counter should be included under

HC.5, medical goods, irrespective of their final purpose.

43. That said, pharmaceuticals for preventive use can be a significant expenditure item

(antihypertensives and statins, for example) and it may well be policy relevant to monitor

their use. In such a case, a country-specific sub-category of HC.5 for preventive medical

goods may be recommended which can be aggregated with all or part of HC.6 categories to

provide a more extensive memorandum item of preventive expenditure.16

16 If a number of countries find this useful, and do hereafter report such preventive pharmaceutical expenditure, then it may be

helpful in future to make recommendations on which specific drugs should be included, perhaps using an

international coding system.

Page 19: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

19

Health interventions to reduce metabolic or physiological risk factors

44. As noted in section 1, some interventions by the healthcare system to change modifiable

metabolic or physiological risk factors might be difficult to distinguish from tertiary

prevention and treatment. A key criterion will be whether the intervention is tackling a risk,

or treating a disease. If the primary aim is, say, to prevent a first heart attack, stroke, or other

major cardiovascular disease, then interventions to reduce metabolic or physiological risk

factors would be included as prevention. It is recognised that it may well be easier to identify

expenditure on organised preventive programmes to tackle, say, high blood pressure in groups

likely to be at risk, than to identify expenditure on similar preventive interventions carried out

individually in regular clinical interactions such as GP visits. As noted above (if separable)

pharmacotherapy is recorded as HC.5, as are contraceptives.

45. Figure 2.5 below illustrates ways of tackling communicable and non-communicable

disease risks, using the same “colour coding” system as Figure 2.2.

Figure 2.5. Approaches to tackling risks, and their SHA classification

Collective measures Individual actions

Collective preventive services – e.g. Epidemiology & programme design Information & communications

- warnings about dangers, and mass media health campaigns

Promotion of prevention services - encouraging uptake of

immunisation, screening, etc Infection prevention/control services

Governance for health – e.g. Formulating safety regulations

- consumer products/services, like sunbeds and tanning

- screening and other services - behavioural services

Exerting strategic influence - Incentives or co-regulation

Health-related actions – e.g. Enforcement of health regulations

- Inspections - monitoring compliance - tackling contraventions

Individual preventive services – e.g. Advising individuals

- assessing risk status and how to reduce risk levels

Immunisation and vaccination Screening and health monitoring Referral to other services

- e.g. behavioural therapies to change risky behaviour

Incentive schemes for healthy behaviour - e.g. to quit smoking

Voluntary measures by individuals and companies may have a primary motivation other than health – e.g. Dietary change

- eg reduced salt, fat, calories Exercise change

- eg use of gyms, bicycles, etc Corporate social responsibility

Pharmaceuticals / medical goods – e.g. Antihypertensives Statins / lipid modifiers Prophylactic anti-obesity and weight

loss drugs Prophylactic anti-viral medication Other prophylactic drugs Oral and barrier contraceptives

Policies where primary motivation is likely to be other than health – e.g. Active travel policies

- safer walking and cycling routes Fiscal and licensing policies

Examples of Risks

Infections

Cancer

Overweight

Blood pressure

Blood lipids

Other Non-Communicable

Diseases

Page 20: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

20

Summary of the prevention boundary under SHA 2011

46. Using the above guidance, the Tables below indicates where to classify different areas of

prevention spending.

Individual prevention services

Prevention category

SHA 2011 code

Examples of relevant activities

Information, education and communication “IEC”

HC.6.1 Providing health and safety-related information to the public, or specific groups (eg firms or workers), about risks and how to reduce them, e.g.:

the importance of specific risks and their potential to kill people, or injure, or cause harm to human health

how to avoid risks, how to increase safety

information about obligations under relevant regulations

production of guidance documents and other media

working with other professionals to design safety or health campaigns [intermediate consumption, but can be allocated to the relevant service]

designing training courses that teach healthy and safe practices [intermediate consumption, but can be allocated to the relevant service]

provision of advisers or counsellors who advise about risks and their reduction

promotion of uptake of any of above

Counselling, behaviour change programmes, and “nudges”

HC.6.1 Motivating to change behaviour, provided primary intent is health – to reduce risks of disease, injury or death

counselling to improve motivation

behavioural counselling

changing presentation of choices, and similar “nudges”

Incentive schemes HC.6.5 Incentive payments or rewards for behaviour change – e.g. for quitting smoking or losing weight

subsidies for healthier consumption – e.g. vouchers for eating more fruit and vegetables

subsidies for personal protective equipment

Immunisation programmes

HC.6.2 Vaccination – typically undertaken by clinical professionals

Screening programmes

HC.6.3 Early detection of disease or risks before disease appears

eg prostate specific antigen testing, or mammography – typically undertaken by clinical professionals

Healthy condition monitoring

HC.6.4 Check-ups, which may be targeted at specific groups

eg regular pregnancy or dental checks – typically undertaken by clinical professionals

Pharmacotherapy HC.5 Preventive medicines such as antihypertensives, statins, other prophylactic medication and contraceptives [where separable from preventive programmes] – from pharmacies or prescribed by clinical professionals

Page 21: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

21

Collective prevention services

Prevention category

SHA 2011 code

Examples of relevant activities

Information, education and communication “IEC”

HC.6.1 Mass media and advertising campaigns

Changing presentation of choices, and similar “nudges”

Surveillance and analysis of risks, and control programmes

HC.6.5 Data collection on risks to human health and safety – eg mortality and morbidity rates

Data recording and information systems – those parts that relate to health and safety risks

Epidemiological assessment, and analysis of causes and consequences of risks, trends, etc

Prevention programme planning and design – eg deciding which programmes are most effective and cost-effective

Evaluation of health and safety programmes

Monitoring of drinking water in public health laboratories

On the job training to better perform these activities

Preparing for disasters, emergencies and response

HC.6.6 Includes designing capacity to respond to health and safety extreme events, and training in how to respond

Governance (making regulations)

HC.7.1 Design and formulation of regulations to protect human health, reduce hazards and increase human safety – eg:

Making provision, or use, of safety equipment mandatory

Requiring specific design amendments, to reduce human mortality or morbidity risks

Prohibitions, such as emissions of health-damaging pollutants or use of carcinogens

Requiring training in safe handling of potentially hazardous substances

Restrictions on advertising (in order to protect health)

Making mandatory health or safety warnings and labelling requirements

Co-regulation (Govt support for this)

HC.7.1 Government efforts to organise and promote a response from other organisations, so as to protect human health, reduce hazards and increase human safety, as an alternative to bringing in regulations

Page 22: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

22

Other services

Category SHA 2011 code

Examples of relevant activities

Enforcement (by official enforcers)

HCR.2 Enforcing health and safety regulations – e.g. inspection, monitoring, and tackling contraventions – costs to the public sector

Multi-sectoral health promotion

HCR.2 Health protection may be an important secondary goal rather than the primary purpose – e.g.

food & water security measures

safe management of waste

tackling drunkenness

Planning fiscal measures (Govt support for this)

[other gov’t]

Design and formulation of taxes on substances that are hazardous to health – eg on tobacco, alcohol, saturated fat Design and formulation of tax exemptions or rebates on things that protect health and reduce mortality and morbidity risks

Compliance costs [other private]

Costs to those regulated:

costs of following mandatory procedures, equipment, training, record keeping, etc

licence fees

fines, taxes paid

Page 23: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

23

3. MAPPING TO NEW 2nd

DIGIT PREVENTION CLASSES

47. The 2nd

digit classes of prevention in SHA 2011 are organised in a different way to those

of SHA 1.0 – following disease stage, type of service, and purpose. SHA 2011 has a table to

help with the mapping from SHA 1.0 to SHA 2011 (Table 3.1).

Table 3.1 Preventive and public health components in SHA 1.0 and SHA 2011

Mapping from SHA 1.0 to SHA 2011 – examples from England

48. Prevention expenditure in England was the subject of a special study.17

This study has

been updated and expenditures classified according to both the SHA 1.0 and SHA 2011

prevention 2nd

digit classes. The exercise was useful in indicating the large share – around

half – of preventive spending going to “healthy monitoring”, HC.6.4, such as routine check-

ups. It also highlighted that preventive pharmaceuticals would be the largest single element

(and was recorded as a memorandum item). The effect of boundary changes between SHA

1.0 and SHA 2011 was to increase prevention expenditure by about 6%. This mapping

exercise raised a number of other issues, which are covered below.

Some additional guidance on using SHA 2011 2nd

digit prevention classes

Data disaggregation

49. One general issue concerns aggregation of data. Sometimes the available data are

aggregated to a relatively high level, and therefore cover more than one prevention category.

17 Health England (2009) http://www.healthengland.org/publications/HealthEnglandReportNo4.pdf

Content: mostly as described in SHA.1Programme

Code SHA.2

New

item

Programme

Code SHA.1Content: mostly as described in SHA.1

Programme

Code SHA.2

New

item

Programme

Code SHA.1

Maternal and child health; family planning and

counselling HC.6.1 Prevention of non-communicable diseases HC.6.4

Genetic counselling HC.6.1 HC.6.1 Health education HC.6.1 HC.6.4

Identification of genetic abnormalities HC.6.3 HC.6.1 Disease prevention HC.6 HC.6.4

Prenatal and postnatal medical care HC.6.4 HC.6.1 Health promotion HC.6. HC.6.4

Baby health care HC.6.4 HC.6.1 Programmes of risk avoidance HC.6.1 HC.6.4

Pre-school and school child health HC.6.4 HC.6.1

Improvement of health status not directed specifically

towards communicable disease HC.6.4 HC.6.4

Programme design, monitoring and evaluation HC.6.5

Interventions against smoking, alcohol and substance

abuse HC.6.1 HC.6.4

Regulation linked to basket of services and population

coverage on MCH, FP HC.7.1 Activities by community workers HC.6 HC.6.4

School health services HC.6.2 Services provided by self-help groups HC.6.1 HC.6.4

Education HC.6.1 HC.6.2 General health education and health information HC.6.1 HC.6.4

Screening HC.6.3 HC.6.2 Health education campaigns HC.6.1 HC.6.4

Disease prevention HC.6 HC.6.2 Campaigns in favour of health promotion (life style, sex, etc) HC.6.1 HC.6.4

Health promotion HC.6 HC.6.2 Information exchanges (alcoholism, drug addiction) HC.6.1 HC.6.4

Basic medical treatment (including dental care) HC.1 HC.6.2 Public health environmental surveillance HC.6.5 HC.6.9

Interventions against smoking, alcohol and substance

abuse (in school) HC.6.1 HC.6.2 Public information on environmental conditions HC.6.1 HC.6.9

Vaccination programmes HC.6.2 HC.6.3 Programme design, monitoring and evaluation HC.6.5

Programme design, monitoring and evaluation HC.6.5

Regulation linked to basket of services and population

coverage on non-communicable diseases HC.7.1

Regulation linked to basket of services and population

coverage on school health HC.7.1 Occupational health care HC.6.5

Prevention of communicable diseases HC.6.3 Surveillance of employee health HC.6.4 HC.6.5

Compulsory reporting and notification of diseases HC.6.5 HC.6.3 Routine medical check up HC.6.4 HC.6.5

Epidemiologic enquiries of communicable diseases HC.6.5 HC.6.3 Therapeutic care, including emergency services HC.1 HC.6.5

Trace contacts and origin of disease HC.6.5 HC.6.3 Ergonomy, safety HC.6 (health part) Excluded

Prevention of tuberculosis HC.6 HC.6.3 Health and environmental protection at work HC.6 (health part) Excluded

Tuberculosis control (screening) HC.6.3 HC.6.3 Accident prevention at work HC.6 (health part) Excluded

Immunization/vaccination (compulsory and voluntary) HC.6.2 HC.6.3 Programme design, monitoring and evaluation HC.6.5

Vaccination under maternity and child care HC.6.2 HC.6.3

Regulation linked to basket of services and population

coverage on occupational health HC.7.1

Vaccination for occupational health HC.6.2 Exc HC.6.5 All other miscellaneous public health services HC.6.9

Vaccination for travel and tourism on patient's initiative HC.1 HC.1 Operation and administration of blood and organ banks HC.4.1.2 HC.6.9

Programme design, monitoring and evaluation HC.6.5 Public health environmental surveillance HC.6.5 HC.6.9

Regulation linked to basket of services and population

coverage on communicable diseases HC.7.1 Public information on environmental conditions HC.6.1 HC.6.9

Page 24: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

24

If data cannot be disaggregated further, then a general rule is that the aggregated expenditure

should be allocated to that area which takes the largest part of the spending.

50. For example, it may not be possible, in some countries, to disaggregate some services

such as child health or school health. If so, they should be allocated by the dominant purpose.

So if, say, the main purpose was healthy condition monitoring, the spending should be

allocated to HC.6.4.

HC.6.1

Information, education & counselling / contraception

51. Family planning and contraceptives would naturally go together. But the counselling

element would be under HC.6.1 while contraceptives are in HC.5.

52. Guidance. Unless they are an integral part of a prevention programme, any medical goods

dispensed against a prescription or purchased over the counter should be included under

HC.5, irrespective of their final purpose. Therefore, any contraceptives bought or dispensed

outside of a health system contact, e.g. doctor consultation, should be excluded from HC.6.1.

If the costs cannot be disaggregated, then they should be allocated according to whether the

counselling or the contraceptives take the larger part of the spending.

Information & education about health/safety by other ministries / public bodies

53. The UK Department for Transport has for many years produced health and safety

campaigns – for example to explain the need to wear seatbelts and to warn people about the

dangers of drinking alcohol and driving. See the example below.

“THINK! provides road safety information for road users. Our aim is to encourage safer behaviour to reduce the number of people killed and injured on our roads every year.” http://think.direct.gov.uk/index.html

_ 54. Guidance. All spending on health promotion, that aims to avoid or reduce the number or

the severity of injuries and diseases, should be included irrespective of the provider or

financing.

HC.6.2

Immunisation for tourism

55. Vaccination for travel and tourism at the patient’s initiative is allocated to treatment

(HC.1) – see table on page 23 above – whereas immunisation when not for travel and tourism

is allocated to HC6.2. The UK NHS provides (free) travel vaccines for cholera and hepatitis,

for example – so this is part of an organised NHS programme. But, of course, the patient also

has to take the initiative and tell their GP when and where they are going to travel.

56. Guidance. This exclusion from prevention was largely due to the practical issue of being

able to gather data on spending outside of organised prevention programmes. Vaccination is

always aimed at prevention. So, if expenditure is identifiable, it should be included in

HC.6.2.

Page 25: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

25

HC.6.3

Early disease detection / prison health

57. The UK has a programme of public health expenditure in prisons. It includes, for

example, screening for hepatitis and other diseases. The activities go wider than this, but

cannot, at present, be disaggregated further.

58. Guidance. In the absence of any other information to allow disaggregation, expenditures

should be allocated to the dominant category.

HC.6.4

Health checks v. screening

59. How clear is the difference between a health check and early disease detection? Does a

health check (initiated by the health system – e.g. for all people aged 50+) for multiple

specific diseases go under HC.6.3 or HC.6.4? (e.g. if the check screens for a range of specific

factors – e.g. smoking status, blood pressure, cholesterol, drinking, etc.)

60. Guidance. There are two potential differences between HC.6.3 and HC.6.4. The first is

that “healthy monitoring” tends to be universally available for all in particular groups – e.g.

all pregnant women, or all people with teeth, can have regular check-ups. Screening

programmes (HC.6.3) tend to select a higher risk group. The second is that screening

programmes tend to try to detect a single disease – eg bowel cancer – or elevated risk of a

particular disease – eg CVD – and use a particular protocol related to that disease. Healthy

monitoring, on the other hand, would tend to look for a wider range of possible diseases or

risks.

Individual development monitoring

61. Within the UK’s NHS the main activities of “health visitors” (trained community nurses)

are the monitoring of the development of newborn infants, and young children. This was not

previously included as prevention under SHA 1.0 as it is a one-to-one service according to

individual need, rather than being seen as a “social programme”.

62. Guidance. SHA 2011 does not make the distinction between a social programme and

individual prevention services in the way that SHA 1.0 did. If it can be identified apart then it

should be included. The phrase “social programme” in SHA 1.0 (p 122) does not have a

narrow definition – e.g. it does not just mean collective provision – and a social programme

can be delivered to individuals according to their specific needs.

Healthy condition monitoring programmes

63. Does this include the monitoring of how well specific risks are controlled? For example,

borderline hypertension may be monitored. How low does a risk have to be to fit the

definition of “healthy condition”?

64. Guidance. There are two potential distinctions between HC.6.3 and HC.6.4 – the breadth

of the group included and the breadth of the disease profile considered. A focus on a

particular group – eg those at high risk of hypertension – and a focus on one particular disease

– eg CVD – would suggest that this should be classified as screening (HC.6.3).

Page 26: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

26

HC.6.5

Incentive payments

65. The UK’s “Healthy Start” programme offers financial incentives (vouchers) for a

healthier diet – the vouchers incentivise change to a healthier diet by providing a subsidy to

purchase fruit and vegetables and other healthy foods.

66. Guidance. When the main purpose is to prevent morbidity, financial incentive payments

should be included under HC.6.5. (If, however, there was some other main purpose – eg

reducing poverty – then they should be excluded from health spending altogether.)

67. The categorisation of incentive schemes designed to change risky behaviour may not be

obvious in SHA 2011. When part of an approach to empower and encourage people to

change their behaviour, through improving their knowledge, beliefs and attitudes, perhaps

using techniques such as motivational interviewing18, these could be seen as part of

“counselling” within IEC (information, education and communication) and thus in HC.6.1.

Some schemes go beyond counselling and include rewards to participants for successful

behaviour change – e.g. a financial reward that varies according to weight lost19. In the latter

case they could be seen as part of a risk control programme, and thus in HC.6.5.

Cost-effectiveness advice

68. Should guidance on public health and prevention, from bodies such as UK’s NICE, go

under HC.6.5 (as prevention planning and evaluation) or under HC.6.1 (as advice)? Where

should other NICE guidance relating to “cure” (planning and evaluation) go?

69. Guidance When directed at specific health or risky behaviours, and where the audience

for the guidance is the public, this should be classed as HC.6.1. General guidance on the cost-

effectiveness of preventive services for use by those planning prevention programmes, and

designing the health system, should be allocated to the class HC.6.5. General guidance on the

cost-effectiveness of curative services (and the making of regulations) should be allocated to

the class HC.7.1.

HC.7.1

Regulation and enforcement within the same body

70. The UK’s Food Standards Agency’s expenditure can be allocated to different functions of

IEC, regulation, and enforcement. See Figure 3.1 below. Expenditure on the UK’s Health

and Safety Executive was not previously included under SHA 1.0. Its primary purpose is to

“prevent people being killed, injured or made ill by work” (http://www.hse.gov.uk/). It has a

mix of functions, like the Food Standards Agency. However, its expenditure is not

disaggregated by these functional classes.

71. Guidance. In the absence of any other information to allow disaggregation, expenditures

should be allocated to the dominant category.

18 Motivational interviewing attempts to increase the client's awareness of the potential problems caused,

consequences experienced, and risks faced as a result of the behaviour in question, and to improve

their motivation to change http://en.wikipedia.org/wiki/Motivational_interviewing

19 ‘The ‘Pounds for Pounds’ weight loss financial incentive scheme’, Relton et al (2011):

http://jpubhealth.oxfordjournals.org/content/early/2011/03/28/pubmed.fdr030.full

Page 27: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

27

Figure 3.1. Spending by the UK Food Standards Agency, by type of activity20

.

Planning versus governance

72. HC.6.5 (Program design, monitoring and evaluation) is sometimes not easily

distinguishable from HC.7.1 (Governance and health system administration), as the former is

one of the principal functions of health administration.

73. Guidance. The difference between HC.6.5 and HC.7.1 could usefully be explained

further. A key difference for current purposes is whether regulations are involved –

regulations that make something mandatory or proscribe something. The health ministry and

parliament may have the power to make regulations, but other bodies may not have such

authority, in which case the activities of these other organisations could be allocated to

HC.6.5.21

20 Food Standards Agency’s resource needs for 2011-12; source: Food Standards Agency, 2011, “The Food

Standards Agency’s Strategy to 2015”:

http://www.food.gov.uk/multimedia/pdfs/strategy20102015.pdf

21 Programme is a plan of action aimed at accomplishing a clear business objective, with details on what work is to

be done, by whom, when, and what means or resources will be used. Regulation is a principle or rule (with or

without the coercive power of law) employed in controlling, directing, or managing an activity, organization, or

system. ( www.businessdictionary.com ).

Page 28: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

28

4. CONCLUSIONS

74. Prevention is a vital investment in health. Prevention spending varies across countries,

but so do reporting methods. While SHA 2011 emphasises purpose in setting boundaries and

categories, in practice other factors may influence what is included or excluded. Important

areas touching the global boundary of health and prevention include transport safety, and

health protection and safety at work, and in the domestic environment; while environmental

health, food safety and individual behaviour touch the health-related boundary; the guidance

proposals in this paper are meant to clarify and harmonise what should be included as

prevention expenditure. Key points include: that, in non-healthcare providers, enforcement of

regulations should be classed as health-related; and except where health services invite or

encourage patients to take the initiative, other actions at the initiative of individuals, firms or

workers should normally be put outside the boundary of “healthcare”.

75. Within health spending, purpose is the key to distinguishing what should be included as

prevention, and into which prevention sub-category expenditure should be allocated.

Proposals are offered to clarify, inter alia, the treatment of patient-initiated requests,

pharmaceuticals and contraceptives, prevention in at-risk groups, and distinguishing planning

from governance.

Page 29: EXPENDITURE ON PREVENTION ACTIVITIES UNDER SHA 2011 ... · including prophylactic medication and contraceptives, is classed with medical goods rather than preventive spending under

29

REFERENCES

Commission on Social Determinants of Health (M.Marmot, chair), ‘Achieving health equity:

from root causes to fair outcomes’ The Lancet, Volume 370, Issue 9593, pp 1153-63, 29th

September 2007.

Food Standards Agency, UK, 2011, “Safer Food for the Nation: The Food Standards

Agency’s Strategy to 2015”. http://www.food.gov.uk/multimedia/pdfs/strategy20102015.pdf

Health England (R.Butterfield, J.Henderson & R.Scott), Report No 4: Public Health and

Prevention Expenditure in England. 2009.

http://www.healthengland.org/publications/HealthEnglandReportNo4.pdf

Relton, C., M.Strong & J.Li, ‘The ‘Pounds for Pounds’ weight loss financial incentive

scheme’, Journal of Public Health, 2011, pp1-7, Oxford Journals.

http://jpubhealth.oxfordjournals.org/content/early/2011/03/28/pubmed.fdr030.full

System of Health Accounts 1.0, 2000, OECD, Paris. http://www.oecd.org/health/health-

systems/21160591.pdf

System of Health Accounts 2011, 2011, OECD, Paris. http://www.oecd.org/els/health-

systems/asystemofhealthaccounts2011.htm

WHO ‘Health Systems Performance Assessment, Debates, Methods & Empiricism’ (eds

C.Murray & D.Evans), 2003, WHO Geneva. http://www.who.int/publications/2003/hspa/en/

WHO Fact Sheet on Non-Communicable Diseases, September 2011.

http://www.who.int/mediacentre/factsheets/fs355/en/index.html